High Point Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$112K Hold
1,525
0.04% 162
2016
Q3
$122K Hold
1,525
0.03% 163
2016
Q2
$121K Hold
1,525
0.03% 160
2016
Q1
$109K Hold
1,525
0.03% 174
2015
Q4
$128K Sell
1,525
-225
-13% -$18.7K 0.03% 161
2015
Q3
$146K Hold
1,750
0.04% 155
2015
Q2
$146K Hold
1,750
0.04% 159
2015
Q1
$127K Hold
1,750
0.04% 176
2014
Q4
$121K Hold
1,750
0.04% 182
2014
Q3
$114K Hold
1,750
0.04% 183
2014
Q2
$109K Hold
1,750
0.04% 188
2014
Q1
$103K Hold
1,750
0.03% 195
2013
Q4
$89K Hold
1,750
0.03% 199
2013
Q3
$88K Sell
1,750
-75
-4% -$3.93K 0.03% 201
2013
Q2
$90K Buy
+1,825
New +$99.3K 0.03% 197

Other funds holding LLY

High Point Bank & Trust's LLY Position: Q4 2016 in Review

High Point Bank & Trust held its Eli Lilly (LLY) position steady in Q4 2016 at 1,525 shares worth $112K. The position accounts for 0.04% of the portfolio, ranked #162.

High Point Bank & Trust first reported a position in LLY in Q2 2013 and has held it in 15 quarters since. The position peaked at $146K in Q3 2015. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

  • High Point Bank & Trust held 1,525 shares of Eli Lilly worth $112K as of Q4 2016.
  • High Point Bank & Trust left its Eli Lilly share count unchanged in Q4 2016.
  • Eli Lilly made up 0.04% of High Point Bank & Trust's portfolio in Q4 2016, its #162 holding.
  • High Point Bank & Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 15 quarters since.
  • High Point Bank & Trust's Eli Lilly position peaked at $146K in Q3 2015.
  • 1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.